Status:
TERMINATED
The Assessment of Oxidative Stress Markers and the Development of Atrial Fibrillation After Cardiac Surgery
Lead Sponsor:
University of Illinois at Chicago
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the investigators study is to investigate the correlation between naturally occurring chemicals, called reactive oxygen species (ROS), in the blood of human patients and the development...
Detailed Description
Atrial Fibrillation (AF) is a common occurrence after cardiac surgery. This arrhythmia is reported to occur in up to 40% of patients following coronary bypass graft (CABG) surgery. The incidence of AF...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Sinus rhythm at the time of enrollment as documented by ECG, telemetry, or Holter monitoring
- Scheduled for an open heart surgery
- Able to provide informed consent
Exclusion
- Systemic inflammatory diseases (e.g., collagen vascular diseases, infections)
- Malignant neoplasms
- Hyperthyroidism
- Uncontrolled hypertension (blood pressure \> 180/100 at rest) on medications
- An illness that might result in death within 1 year
- Implanted devices for designed for active management of atrial arrhythmias by pacing or defibrillation
- Current illicit drug use
- Current ethanol abuse
- Presence of paroxysmal, persistent, or permanent atrial fibrillation at the time of enrollment
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00846534
Start Date
April 1 2008
End Date
April 1 2013
Last Update
April 23 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612
2
Advocate Christ Medical Center
Oak Lawn, Illinois, United States, 60453